AUA, SUO Issue New Guideline on Nonmetastatic UTUC
The new guideline aims to limit toxicity and improve cancer control and survival in patients with UTUC.
The new guideline aims to limit toxicity and improve cancer control and survival in patients with UTUC.
With effective modern systemic therapies for metastatic RCC, how cytoreductive nephrectomy affects quality of life has become an increasingly relevant question, according to investigators.
CKD risk is increased 3.9-fold for patients who undergo radical vs partial nephrectomy.
In a study, partial vs radical cytoreductive nephrectomy for clear cell metastatic renal cell carcinoma was associated with a 54% decreased risk for other-cause mortality.
Findings may inform treatment decisions after nephrectomy with positive surgical margins.
Nephron-sparing management is one strategy to reduce risks, according to investigators.
Management of metastatic renal cell carcinoma should be highly individualized, according to investigators.
Surgery should be reserved for select patients with oncocytomas, according to investigators.
The decision to undergo partial instead of radical nephrectomy should be individualized, according to investigators.
Percutaneous cryoablation for cT1b renal tumors is associated with a higher rate of local disease recurrence compared with partial nephrectomy, new data suggest.